$410 Million is the total value of SENZAR ASSET MANAGEMENT, LLC's 33 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 90.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STJ | New | ST JUDE MED INC | $47,977,000 | – | 733,600 | +100.0% | 11.69% | – |
| KND | New | KINDRED HEALTHCARE INC | $38,935,000 | – | 1,636,600 | +100.0% | 9.49% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $34,340,000 | +158.6% | 551,197 | +138.7% | 8.37% | +115.0% |
| NVRO | Buy | NEVRO CORP | $25,103,000 | +205.5% | 523,736 | +146.5% | 6.12% | +154.1% |
| SNY | Sell | SANOFIsponsored adr | $23,702,000 | -26.3% | 479,412 | -32.0% | 5.78% | -38.7% |
| LLY | New | LILLY ELI & CO | $22,267,000 | – | 306,500 | +100.0% | 5.43% | – |
| MDXG | New | MIMEDX GROUP INC | $21,861,000 | – | 2,102,059 | +100.0% | 5.33% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $21,309,000 | – | 169,000 | +100.0% | 5.19% | – |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $16,903,000 | +46.5% | 1,116,100 | +28.9% | 4.12% | +21.8% |
| ELOS | Buy | SYNERON MEDICAL LTD | $13,902,000 | +394.9% | 1,122,900 | +272.9% | 3.39% | +311.7% |
| OFIX | Buy | ORTHOFIX INTL N V | $12,317,000 | +33.5% | 343,201 | +11.8% | 3.00% | +11.0% |
| RTRX | Sell | RETROPHIN INC | $11,474,000 | +47.5% | 478,900 | -24.7% | 2.80% | +22.6% |
| RCPT | New | RECEPTOS INC | $11,278,000 | – | 68,400 | +100.0% | 2.75% | – |
| INSM | Sell | INSMED INC | $11,213,000 | +7.0% | 539,107 | -20.4% | 2.73% | -11.0% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $10,564,000 | +50.3% | 695,016 | +19.1% | 2.57% | +25.0% |
| XNPT | Buy | XENOPORT INC | $10,373,000 | +8.6% | 1,456,900 | +33.8% | 2.53% | -9.6% |
| SGNT | Buy | SAGENT PHARMACEUTICALS INC | $9,711,000 | +44.1% | 417,692 | +55.7% | 2.37% | +19.8% |
| PMC | New | PHARMERICA CORP | $7,801,000 | – | 276,714 | +100.0% | 1.90% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $7,198,000 | +49.7% | 2,016,287 | -4.8% | 1.75% | +24.5% |
| TNDM | New | TANDEM DIABETES CARE INC | $7,017,000 | – | 555,986 | +100.0% | 1.71% | – |
| CORI | Buy | CORIUM INTL INC | $6,647,000 | +7.6% | 1,014,820 | +0.2% | 1.62% | -10.5% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $5,259,000 | +46.3% | 568,549 | +10.9% | 1.28% | +21.7% |
| ACTPRA | New | ACTAVIS PLCpfd conv ser a | $4,959,000 | – | 4,900 | +100.0% | 1.21% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $4,725,000 | +110.7% | 154,300 | +249.8% | 1.15% | +75.3% |
| FLML | New | FLAMEL TECHNOLOGIES SAsponsored adr | $4,052,000 | – | 225,351 | +100.0% | 0.99% | – |
| ACRX | Buy | ACELRX PHARMACEUTICALS INC | $4,017,000 | -34.2% | 1,040,681 | +14.8% | 0.98% | -45.3% |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $3,584,000 | – | 150,100 | +100.0% | 0.87% | – |
| BOTA | Buy | BIOTA PHARMACEUTIALS INC | $3,384,000 | +7.3% | 1,471,300 | +4.5% | 0.82% | -10.7% |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $3,056,000 | – | 309,900 | +100.0% | 0.74% | – |
| RPRX | Sell | REPROS THERAPEUTICS INC | $2,096,000 | -72.5% | 244,006 | -68.1% | 0.51% | -77.1% |
| ALQA | New | ALLIQUA BIOMEDICAL INC | $1,367,000 | – | 262,953 | +100.0% | 0.33% | – |
| XENT | New | INTERSECT ENT INC | $1,109,000 | – | 42,927 | +100.0% | 0.27% | – |
| PFNX | New | PFENEX INC | $834,000 | – | 52,300 | +100.0% | 0.20% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -37,700 | -100.0% | -1.01% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -79,500 | -100.0% | -2.32% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -332,474 | -100.0% | -2.63% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -61,900 | -100.0% | -2.83% | – |
| SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -85,400 | -100.0% | -2.88% | – |
| F113PS | Exit | COVIDIEN PLC | $0 | – | -105,862 | -100.0% | -3.17% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -248,900 | -100.0% | -3.28% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -781,800 | -100.0% | -3.51% | – |
| MGLN | Exit | MAGELLAN HEALTH INC | $0 | – | -208,500 | -100.0% | -3.67% | – |
| BIIB | Exit | BIOGEN IDEC INC | $0 | – | -37,800 | -100.0% | -3.76% | – |
| B108PS | Exit | ACTAVIS PLC | $0 | – | -71,600 | -100.0% | -5.40% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -150,300 | -100.0% | -6.30% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -435,100 | -100.0% | -6.88% | – |
| MYL | Exit | MYLAN INC | $0 | – | -463,300 | -100.0% | -7.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CONCERT PHARMACEUTICALS INC | 16 | Q2 2018 | 4.5% |
| SANOFI | 14 | Q2 2018 | 17.6% |
| CORIUM INTL INC | 14 | Q3 2017 | 2.3% |
| FOAMIX PHARMACEUTICALS LTD | 14 | Q2 2018 | 2.1% |
| RETROPHIN INC | 13 | Q2 2017 | 3.0% |
| ALDER BIOPHARMACEUTICALS INC | 12 | Q2 2018 | 3.9% |
| RIGEL PHARMACEUTICALS INC | 12 | Q3 2016 | 1.8% |
| INSMED INC | 11 | Q3 2017 | 6.2% |
| TEVA PHARMACEUTICAL INDS LTD | 10 | Q1 2016 | 12.3% |
| ORTHOFIX INTL N V | 10 | Q1 2017 | 9.0% |
View SENZAR ASSET MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Corium International, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
| Aviragen Therapeutics, Inc. | February 13, 2017 | 1,774,876 | 4.6% |
| CONCERT PHARMACEUTICALS, INC. | February 13, 2017 | 400,588 | 1.8% |
| Foamix Pharmaceuticals Ltd. | February 13, 2017 | 550,997 | 1.5% |
| NEVRO CORPSold out | February 13, 2017 | 0 | 0.0% |
| TIVITY HEALTH, INC. | February 13, 2017 | 383,200 | 1.0% |
| HEALTHWAYS, INC | February 12, 2016 | 2,525,044 | 7.0% |
| Sientra, Inc. | February 12, 2016 | 580,851 | 3.2% |
| Biota Pharmaceuticals, Inc. | January 15, 2016 | 2,025,976 | 5.2% |
View SENZAR ASSET MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-10-31 |
| 13F-HR | 2018-08-13 |
| 13F-HR | 2018-05-14 |
| SC 13G/A | 2018-02-14 |
| 13F-HR | 2018-02-13 |
| 13F-HR | 2017-11-13 |
| 13F-HR | 2017-08-11 |
| 13F-HR | 2017-05-12 |
| 13F-HR | 2017-02-14 |
| SC 13G/A | 2017-02-13 |
View SENZAR ASSET MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.